← Back to Analyst Consensus 
NGEN Buy
NERVGEN PHARMA CORP.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 14, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 13, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| Apr 27, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
Price Target Trend
Mar 31, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days